Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Five Stocks To Buy: Federal Bank, GAIL, Eicher Motors And More | June 16, 2026

Market analysts and brokerage firms have identified high-conviction trading ideas for the upcoming session, focusing on private banking, ene...